One research paper and several review papers will appear in the December issue of Frontiers in Ecology and the Environment. The research study explores Coho salmon dependence on intermittent streams in light of Supreme Court cases, while one of the reviews focuses on the management and biodiversity of sacred groves.
Magnets may interfere with the operation of pacemakers and implantable cardioverter defibrillators, according to a study published in the December 2006 edition of Heart Rhythm.
CERN took delivery of the last superconducting main magnet for the Large Hadron Collider (LHC) on 27 November. This completes the full set of 1624 main magnets required to build the world’s largest and most powerful particle accelerator.
People who experience their first-ever bout of depression after having a heart attack are at greater risk for future heart problems than are patients who either don?t become clinically depressed after the medical emergency or who were depressed even before the incident, new research shows.
The turbidity of red wine during its ageing in oak casks has an influence on the accumulation of volatile compounds and, thereby, on the wine’s aroma, but not on the accumulation of biogenic amines. This is the conclusion of Nerea Jim?nez Moreno in her PhD thesis defended at the Public University of Navarre.
ESA’s gamma-ray observatory, Integral, has spotted a rare kind of gamma-ray outburst. The vast explosion of energy allowed astronomers to pinpoint a possible black hole in our galaxy.
Within the next 10 years the EU-funded Diabetes Prevention study, part of an international study called TRIGR (Trial to Reduce IDDM in the Genetically at Risk), coordinated at the University of Helsinki, Finland, will generate a definite answer to the question whether early nutritional modification may prevent type 1 diabetes later in childhood.
On the occasion of the U.S. Food and Drug Administration’s (FDA) Centennial year, the FDA hosted an inaugural international summit of heads of medical products regulatory agencies in Washington, D.C., November 16-17, 2006.
The largest superconducting magnet ever built has successfully been powered up to its operating conditions at the first attempt. Called the Barrel Toroid because of its shape, this magnet is a vital part of ATLAS, one of the major particle detectors being prepared to take data at CERN’s Large Hadron Collider (LHC), the new particle accelerator scheduled to turn on in November 2007.
Novartis has received a positive opinion supporting European Union regulatory approval for Lucentis? (ranibizumab) as a new treatment option for patients with the “wet” form of age-related macular degeneration, the leading cause of severe vision loss in people over age 50 in the western world.